Gesynta Pharma is a privately-held pharmaceutical company developing novel oral treatments for patients with chronic inflammatory conditions
Total raised: $20.517605M
Founded date: 2017
Investors 2
Date | Name | Website |
- | Industrifo... | industrifo... |
- | Hadean Ven... | hadeanvent... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
07.07.2020 | - | $20.517605... | Industrifo... | - |
Mentions in press and media 2
Date | Title | Description | Category | Author | Source |
15.06.2021 | Gesynta Ph... | Stockholm, Sweden, June 14 202... | - | - | hadeanvent... |
26.01.2021 | Gesynta Ph... | Stockholm, Sweden, January 26,... | - | - | hadeanvent... |